Fulgent Genetics stock has undergone multiple analysts rating changes in the recent past. Fulgent Genetics Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.
Shares of Fulgent Genetics traded down -$1.72 on Tuesday, reaching $82.10. 0 shares of the stock traded hands, compared to its average volume of 468522. Shares of Fulgent Genetics were trading at $82.10 on Tuesday. The firm’s 50 day moving average is $91.21 and its 200 day moving average is $89.97.Fulgent Genetics has a 12 month low of $81.27 and a 12 month high of $189.89. While on yearly highs and lows, Fulgent Genetics’s today has traded high as $86.03 and has touched $81.27 on the downward trend. See More Analyst Rating at: RATING
Fulgent Genetics Earnings and What to expect:
Fulgent Genetics last announced its quarterly earnings results on August 9th, 2021. The reported $2.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.54 by $0.07. The business had revenue of $153.60 million for the quarter, compared to analysts’ expectations of $197.34 million. Its revenue for the quarter was up 789.4% on a year-over-year basis. Fulgent Genetics has generated $8.85 earnings per share over the last year ($17.25 diluted earnings per share) and currently has a price-to-earnings ratio of 4.8. Fulgent Genetics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 8th, 2021 based off prior year’s report dates.
The P/E ratio of Fulgent Genetics is 4.76, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 14.77. The P/E ratio of Fulgent Genetics is 4.76, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 32.64. Fulgent Genetics has a P/B Ratio of 3.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
Fulgent Genetics (NASDAQ:FLGT) Moving Average Technical Analysis
5 day Moving Average is $81.49 And 5 day price change is $2.44 (3.06%) with average volume for 5 day average is 305,720. While technical analysis for average 20 days shows significant difference, 20 day moving average is $85.47 and 20 day price change is -$4.40 (-5.09%) and average 20 day moving volume is 434,400. 50 day moving average is $91.21 and 50 day price change is -$10.66 ( -11.49%) and with average volume for 50 days is : 577,606. 200 day moving average is $89.97 and 200 day price change is $36.33 (79.38%) and with average volume for 200 days is : 1,230,704.
Other owners latest trading in Fulgent Genetics :
- On 10/12/2021 shares held by Stonnington Group LLC were 12,350 which equates to market value of $1.02M and appx 0.20% owners of Fulgent Genetics
- On 10/12/2021 shares held by IFG Advisory LLC were 5,683 which equates to market value of $0.51M and appx 0.10% owners of Fulgent Genetics
- On 10/12/2021 shares held by Louisiana State Employees Retirement System were 9,200 which equates to market value of $0.83M and appx 0.00% owners of Fulgent Genetics
- In total Institutional ownership equates to Institutional Ownership Percentage: 36.07% for Fulgent Genetics
See More Analyst Rating at: RATING